Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1983;15(Suppl 3):439S–445S. doi: 10.1111/j.1365-2125.1983.tb02135.x

Cardiac effects of antidepressant drugs

A comparison of the tricyclic antidepressants and fluvoxamine

J C Roos
PMCID: PMC1427661  PMID: 6407505

Abstract

1 The cardiovascular effects of the tricyclic antidepressants (TCAs) are reviewed and compared with those of fluvoxamine, a new 5-hydroxytryptamine (5-HT) re-uptake inhibitor.

2 The TCAs have important effects on the heart, related to their anticholinergic and quinidine-like properties. The major side effects in therapeutic dosage include heart rate increase, postural hypotension and slight prolongation of the intraventricular conduction time and QT interval. In toxic dosage (or normal dosage in patients with severe heart disease) both advanced heart block and ventricular arrhythmias can occur, together with clinically important loss of myocardial contractile force.

3 Fluvoxamine has no effects on the heart except for a statistically (but not clinically) significant slowing of the heart rate.

Full text

PDF
439S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boakes A. J., Laurence D. R., Teoh P. C., Barar F. S., Benedikter L. T., Prichard B. N. Interactions between sympathomimetic amines and antidepressant agents in man. Br Med J. 1973 Feb 10;1(5849):311–315. doi: 10.1136/bmj.1.5849.311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Briant R. H., Reid J. L., Dollery C. T. Interaction between clonidine and desipramine in man. Br Med J. 1973 Mar 3;1(5852):522–523. doi: 10.1136/bmj.1.5852.522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Burgess C. D., Montgomery S., Wadsworth J., Turner P. Cardiovascular effects of amitriptyline, mianserin, zimelidine and nomifensine in depressed patients. Postgrad Med J. 1979 Oct;55(648):704–708. doi: 10.1136/pgmj.55.648.704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Claassen V., Davies J. E., Hertting G., Placheta P. Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor. Br J Pharmacol. 1977 Aug;60(4):505–516. doi: 10.1111/j.1476-5381.1977.tb07528.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Coull D. C., Crooks J., Dingwall-Fordyce I., Scott A. M., Wier R. D. Amitriptyline and cardiac disease. Risk of sudden death identified by monitoring system. Lancet. 1970 Sep 19;2(7673):590–591. doi: 10.1016/s0140-6736(70)90169-8. [DOI] [PubMed] [Google Scholar]
  6. De Wilde J. E., Doogan D. P. Fluvoxamine and chlorimipramine in endogenous depression. J Affect Disord. 1982 Sep;4(3):249–259. doi: 10.1016/0165-0327(82)90009-x. [DOI] [PubMed] [Google Scholar]
  7. De Wilde J. E., Mertens C., Wakelin J. S. Clinical trials of fluvoxamine vs chlorimipramine with single and three times daily dosing. Br J Clin Pharmacol. 1983;15 (Suppl 3):427S–431S. doi: 10.1111/j.1365-2125.1983.tb02133.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Giardina E. G., Bigger J. T., Jr, Glassman A. H., Perel J. M., Kantor S. J. The electrocardiographic and antiarrhythmic effects of imipramine hydrochloride at therapeutic plasma concentrations. Circulation. 1979 Nov;60(5):1045–1052. doi: 10.1161/01.cir.60.5.1045. [DOI] [PubMed] [Google Scholar]
  9. Glassman A. H., Bigger J. T., Jr, Giardina E. V., Kantor S. J., Perel J. M., Davies M. Clinical characteristics of imipramine-induced orthostatic hypotension. Lancet. 1979 Mar 3;1(8114):468–472. doi: 10.1016/s0140-6736(79)90824-9. [DOI] [PubMed] [Google Scholar]
  10. Guerrera G., Melina D. Effetti cardiaci degli antidepressivi triciclici somministrati a dosi terpeutiche. Minerva Cardioangiol. 1980 Nov;28(11):743–752. [PubMed] [Google Scholar]
  11. Hayes J. R., Born G. F., Rosenbaum A. H. Incidence of orthostatic hypotension in patients with primary affective disorders treated with tricyclic antidepressants. Mayo Clin Proc. 1977 Aug;52(8):509–512. [PubMed] [Google Scholar]
  12. Jandhyala B. S., Steenberg M. L., Perel J. M., Manian A. A., Buckley J. P. Effects of several tricyclic antidepressants on the hemodynamics and myocardial contractility of the anesthetized dogs. Eur J Pharmacol. 1977 Apr 21;42(4):403–410. doi: 10.1016/0014-2999(77)90175-3. [DOI] [PubMed] [Google Scholar]
  13. Kantor S. J., Bigger J. T., Jr, Glassman A. H., Macken D. L., Perel J. M. Imipramine-induced heart block. A longitudinal case study. JAMA. 1975 Mar 31;231(13):1364–1366. [PubMed] [Google Scholar]
  14. Klok C. J., Brouwer G. J., van Praag H. M., Doogan D. Fluvoxamine and clomipramine in depressed patients. A double-blind clinical study. Acta Psychiatr Scand. 1981 Jul;64(1):1–11. doi: 10.1111/j.1600-0447.1981.tb00756.x. [DOI] [PubMed] [Google Scholar]
  15. Laddu A. R., Somani P. Desipramine toxicity and its treatment. Toxicol Appl Pharmacol. 1969 Sep;15(2):287–294. doi: 10.1016/0041-008x(69)90029-5. [DOI] [PubMed] [Google Scholar]
  16. MANN A. M., CATTERSON A. G., MACPHERSON A. S. Toxicity of imipramine: report on serious side effects and massive overdosage. Can Med Assoc J. 1959 Jul 1;81(1):23–28. [PMC free article] [PubMed] [Google Scholar]
  17. MULLER O. F., GOODMAN N., BELLET S. The hypotensive effect of imipramine hydrocloride in patients with cardiovascular disease. Clin Pharmacol Ther. 1961 May-Jun;2:300–307. doi: 10.1002/cpt196123300. [DOI] [PubMed] [Google Scholar]
  18. Meyer J. F., McAllister C. K., Goldberg L. I. Insidious and prolonged antagonism of guanethidine by amitriptyline. JAMA. 1970 Aug 31;213(9):1487–1488. [PubMed] [Google Scholar]
  19. Moir D. C., Cornwell W. B., Dingwall-Fordyce I., Crooks J., O'Malley K., Turnbull M. J., Weir R. D. Cardiotoxicity of amitriptyline. Lancet. 1972 Sep 16;2(7777):561–564. doi: 10.1016/s0140-6736(72)91958-7. [DOI] [PubMed] [Google Scholar]
  20. Müller V., Burckhardt D. Die Wirkung tri- und tetrazyklischer Antidepressiva auf Herz und Kreislauf. Schweiz Med Wochenschr. 1974 Dec 21;104(51):1911–1913. [PubMed] [Google Scholar]
  21. Robinson J. F., Doogan D. P. A placebo controlled study of the cardiovascular effects of fluvoxamine and clovoxamine in human volunteers. Br J Clin Pharmacol. 1982 Dec;14(6):805–808. doi: 10.1111/j.1365-2125.1982.tb02040.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Saletu B., Schjerve M., Grünberger J., Schanda H., Arnold O. H. Fluvoxamine-a new serotonin re-uptake inhibitor: first clinical and psychometric experiences in depressed patients. J Neural Transm. 1977;41(1):17–36. doi: 10.1007/BF01252962. [DOI] [PubMed] [Google Scholar]
  23. Scherlag B. J., Lau S. H., Helfant R. H., Berkowitz W. D., Stein E., Damato A. N. Catheter technique for recording His bundle activity in man. Circulation. 1969 Jan;39(1):13–18. doi: 10.1161/01.cir.39.1.13. [DOI] [PubMed] [Google Scholar]
  24. Thorstrand C. Cardiovascular effects of poisoning with tricyclic antidepressants. Acta Med Scand. 1974 Jun;195(6):505–514. doi: 10.1111/j.0954-6820.1974.tb08179.x. [DOI] [PubMed] [Google Scholar]
  25. Veith R. C., Friedel R. O., Bloom V., Bielski R. Electrocardiogram changes and plasma desipramine levels during treatment of depression. Clin Pharmacol Ther. 1980 Jun;27(6):796–802. doi: 10.1038/clpt.1980.113. [DOI] [PubMed] [Google Scholar]
  26. Vohra J., Burrows G. D., Sloman G. Assessment of cardiovascular side effects of therapeutic doses of tricyclic anti-depressant drugs. Aust N Z J Med. 1975 Feb;5(1):7–11. doi: 10.1111/j.1445-5994.1975.tb03247.x. [DOI] [PubMed] [Google Scholar]
  27. Vohra J., Burrows G., Hunt D., Sloman G. The effect of toxic and therapeutic doses of tricyclic antidepressant drugs on intracardiac conduction. Eur J Cardiol. 1975 Oct;3(3):219–227. [PubMed] [Google Scholar]
  28. Weld F. M., Bigger J. T., Jr Electrophysiological effects of imipramine on ovine cardiac Purkinje and ventricular muscle fibers. Circ Res. 1980 Feb;46(2):167–175. doi: 10.1161/01.res.46.2.167. [DOI] [PubMed] [Google Scholar]
  29. Williams R. B., Jr, Sherter C. Cardiac complications of tricyclic antidepressant therapy. Ann Intern Med. 1971 Mar;74(3):395–398. doi: 10.7326/0003-4819-74-3-395. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES